title: [Proliferation kinetics of Ehrlich ascites tumors during cisplatin administration].
abstract: In order to study the relationship between numerical growth and DNA-frequency distribution of tumor cells model experiments were made on the Ehrlich ascites tumor of mice after a single doses of the cytostatic cis-Platin. In 84 mice the tumor growth was measured by cell counting and the DNA-histogram by flow-cytometry. With exception of the controls 4, 8, 16 mg cis-Pt/kg were applied i.p. at the 5th day of tumor growth. An inhibition or a retardation of tumor growth is always observed. The 4 mg doses leads to a G2-blockade resulting in an increase of the G2-peak in the DNA-histogram after 2 days (7th day of growth). After 7 days of tumor growth) the effect has been mainly subsided. The effect of 16 mg/kg is a blockade of G2- and S-phase as well, connected with a complete inhibition of tumor growth. Therefore after two days (7th day of growth) this DNA-histogram is very similar to that of the control. Later on a recovery of DNA-synthesis occurs while the G2-blockade is still existing. Therefore the G2-peak is very marked 7 days after application (12th day of growth). All doses result in a disturbance of higher ploid cycles with an increase of hyper-8c-nuclei.
authors.affiliation: Abteilung Quantitative Morphologie, Karl-Marx-Universität Leipzig.
authors.forename: H
authors.initials: H
authors.lastname: Krug
authors.forename: G
authors.initials: G
authors.lastname: Taubert
authors.forename: S
authors.initials: S
authors.lastname: Lenschow
mesh_terms: D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000473:pathology*; D002453:Cell Cycle; D002455:Cell Division; D002945:Cisplatin / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D007700:Kinetics; D051379:Mice; D008815:Mice, Inbred Strains
chemical_list: D004273:DNA, Neoplasm; D002945:Cisplatin
vernacular_title: Proliferationskinetik des Ehrlich-Aszites-Tumors unter cis-Platin.